Terbinafine Hydrochloride Price Trend

Terbinafine Hydrochloride Price Trend, Index and Forecast  

Track the latest insights on terbinafine hydrochloride price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania. 

Terbinafine Hydrochloride Prices Outlook Q1 2025  

• USA: US$ 196/KG  
• India: US$ 90/KG 
• Germany: US$ 116/KG 
• Brazil: US$ 150/KG 
• Spain: US$ 132/KG 

Terbinafine Hydrochloride Price Chart

Get real-time access to monthly/quaterly/yearly prices, Request Sample

During the first quarter of 2025, the terbinafine hydrochloride prices in the USA reached 196 USD/KG in March. As per the terbinafine hydrochloride price chart, prices varied due to worries about trade and uncertainty regarding supply. January experienced a surge due to the acceleration of pre-tariff imports and increasing logistical expenses. Prices fell in February as China restarted production and shipping became easier. By March, prices were revived by renewed purchasing and concerns related to tariffs.  

During the first quarter of 2025, the terbinafine hydrochloride prices in India reached 90 USD/KG in March. The market experienced significant fluctuations. Driven by increasing pharmaceutical exports and domestic demand, bolstered by global restocking, prices surged in January. In February, a downturn occurred due to supply exceeding demand, leading buyers to steer clear of new purchases. March experienced a rebound as exporters hurried shipments to the U.S. before looming tariffs, which tightened local availability.  

During the first quarter of 2025, the terbinafine hydrochloride prices in Germany reached 116 USD/KG in March. Prices were subject to fluctuations. The moderate gains in January were driven by strong demand in the healthcare sector and strategic stockpiling. February experienced a price decline owing to adequate supply, robust Euro performance, and reduced shipping expenses. The mild recovery observed in March was ascribed to supply delays caused by labor unrest and port congestion. 

During the first quarter of 2025, the terbinafine hydrochloride prices in Brazil reached 150 USD/KG in March. Prices fluctuated as a result of varying demand and external factors such as enhanced logistics and accumulated inventories. In March, a resurgence in demand for pharmaceuticals and supply chain issues led to a slight recovery in prices. The quarter concluded with slight gains, indicative of a market adjusting to changes in global trade and localized supply constraints. 

During the first quarter of 2025, the terbinafine hydrochloride prices in Spain reached 132 USD/KG in March.  The market experienced fluctuations. Prices rose in January because of proactive buying ahead of the Chinese New Year and robust demand from the pharmaceutical sector. February experienced a decline due to steady imports, reduced transport rates, and inventory accumulation, which diminished buying momentum.

Terbinafine Hydrochloride Prices Outlook Q4 2023

• India: US$ 62,466/MT

In the fourth quarter of 2023, the manufacturing sector of India seemed to slow down as the new orders, output, exports, and invoices all showed a downtrend. Increasing the terbinafine hydrochloride stock and the drop in demand due to a lesser number of fungal cases in winter led to a price decrease. Despite the quarterly downturn, market analysts remain optimistic about future price stability and potential increases, attributing this bullish outlook to expectations of a rebound in demand. Q4 2023 price of terbinafine hydrochloride reached 62,466 USD/MT.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the terbinafine hydrochloride prices. 

Global Terbinafine Hydrochloride Price Trend

The report offers a holistic view of the global terbinafine hydrochloride pricing trends in the form of terbinafine hydrochloride price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price levels but also provides insights into historical price of terbinafine hydrochloride, enabling stakeholders to understand past fluctuations and their underlying causes. The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed terbinafine hydrochloride demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape. 

Europe Terbinafine Hydrochloride Price Trend

Q1 2025: 

As per the terbinafine hydrochloride price index, there were significant fluctuations driven by alterations in demand and supply dynamics. January saw a moderate rise, fueled by robust demand from major European markets and stockpiling efforts in anticipation of the Chinese Lunar New Year. In February, prices softened due to stable supply and weakening demand. Moreover, in March, supply disruptions due to port congestion and labor strikes contributed to a minor price hike. As the pharmaceutical sector began to recover and restocking activities intensified, demand increased, resulting in a slight price rebound.  

Q4 2023:

The terbinafine hydrochloride market in Q4 of 2023 in Europe was characterized by price changes impacted by several factors. Foreign exchange fluctuations, monetary tightening, and deteriorating consumer morale were among the factors that affected the situation. Consumers' spending and consumption shrank significantly, and a notable deficit in demand for terbinafine hydrochloride ensued since high interest rates hampered individuals' economic capacity. Moreover, the strengthening of the euro against the US dollar paved the way for low-cost imports, offering a large amount of the drug in the German market.

This analysis can be extended to include detailed terbinafine hydrochloride price information for a comprehensive list of countries.

North America Terbinafine Hydrochloride Price Trend

Q1 2025: 

The market varied as a result of unpredictable supply chain issues and changing trade policies. This, combined with escalating energy expenses and the imminent arrival of the Chinese Lunar New Year, resulted in a temporary price surge. In February, however, costs declined as production in China recovered after the holiday and freight rates fell, leading to improved import flows. Market conditions were weakened by economic uncertainty and decreased demand from prior stockpiling. Prices saw a slight increase by March due to concerns about the continuity of pharmaceutical supply following tariff announcements from the U.S. government. The quarter ended with a slight price recovery, fueled by renewed buying interest and ongoing concerns about the supply chain. 

Q4 2023:

The final quarter of 2023 in North America was marked by the occurrence of several key factors that affected the pricing dynamics of terbinafine hydrochloride. Initially, the prices went slightly down in the context of shrinking demand from the healthcare and pharmaceutical sector bringing up an oversupply situation. However, the Federal Reserve Bank as a result supported by its interest rates since the sustained levels play a significant role in reducing consumer purchasing power and adding to the downward trend in the price of goods.

Specific terbinafine hydrochloride historical data within the United States and Canada can also be provided.

Middle East and Africa Terbinafine Hydrochloride Price Trend

Q1 2025: 

The report explores the terbinafine hydrochloride trends and terbinafine hydrochloride price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices. 

In addition to region-wise data, information on terbinafine hydrochloride prices for countries can also be provided.

Asia Pacific Terbinafine Hydrochloride Price Trend

Q1 2025: 

Prices in India showed a volatile pattern due to changes in demand and supply factors. In January, prices improved due to the growth of domestic pharmaceutical sales and rising exports in expectation of higher tariffs. The growth of the Indian Pharma Market, coupled with robust international demand, enabled suppliers to increase prices. February saw a decline, as consistent domestic production fulfilled supply needs and global demand weakened amid uncertainties in the U.S. and Europe. Prices bounced back in March due to the tightening of domestic supplies and Indian exporters accelerating their shipments to the U.S. in anticipation of the April tariff deadline.  

Q4 2023:

During the fourth quarter of 2023, multiple factors influenced the price fluctuations of terbinafine hydrochloride in the Asia Pacific region. The primary cause, particularly the decay in demand from the healthcare and pharmaceutical industries, was the price reduction. Furthermore, a larger supply of terbinafine hydrochloride lowered the price point even further. Additionally, the contraction in the advanced economies and slowing down worldwide trade that followed hindered exports and led to dull investor attitudes. In particular, the Indian manufacturing sector as of the fourth quarter experienced a slowdown, which was indicated by falling order intake, production levels, export development, and purchasing activity.

This terbinafine hydrochloride price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Terbinafine Hydrochloride Price Trend

Q1 2025: 

Prices in India showed a volatile pattern due to changes in demand and supply factors. In January, prices improved due to the growth of domestic pharmaceutical sales and rising exports in expectation of higher tariffs. The growth of the Indian Pharma Market, coupled with robust international demand, enabled suppliers to increase prices. February saw a decline, as consistent domestic production fulfilled supply needs and global demand weakened amid uncertainties in the U.S. and Europe. Prices bounced back in March due to the tightening of domestic supplies and Indian exporters accelerating their shipments to the U.S. in anticipation of the April tariff deadline.  

Q4 2023:

The analysis of terbinafine hydrochloride prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Terbinafine Hydrochloride Price Trend, Market Analysis, and News

IMARC's latest publication, “Terbinafine Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the terbinafine hydrochloride market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of terbinafine hydrochloride at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed terbinafine hydrochloride prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting terbinafine hydrochloride pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting. 

Terbinafine Hydrochloride Market Analysis

The global terbinafine hydrochloride market size reached USD 1.33 Billion in 2024. By 2033, IMARC Group expects the market to reach USD 3.26 Billion, at a projected CAGR of 9.98% during 2025-2033.

• Continual advancements in pharmaceutical formulations and manufacturing processes contribute to product innovation and market expansion.
• The strategic partnerships and collaborations among pharmaceutical companies facilitate market growth and penetration into emerging economies.
• An enhanced focus on healthcare and dermatological wellness fuels the demand for Terbinafine Hydrochloride-based treatments.
• Regulatory approvals and compliance standards play a crucial role in market access and product adoption, influencing market dynamics and competitiveness.
• The growing adoption of telemedicine and e-pharmacies facilitates easier access to Terbinafine Hydrochloride products, particularly in remote or underserved areas.
• The lifestyle changes, including increased participation in sports and outdoor activities, elevate the risk of fungal infections, further stimulating market demand for antifungal treatments like Terbinafine Hydrochloride.
• The evolving consumer preferences towards self-care and over-the-counter (OTC) medications drive sales of Terbinafine Hydrochloride products in retail pharmacies and online platforms.
• The emergence of novel drug delivery systems and formulations enhances patient compliance and convenience, fostering market growth by expanding the range of available treatment options.
• The rise in healthcare expenditure and access to healthcare services in developing regions fosters market growth by expanding the patient pool seeking treatment for fungal infections.
• Rapid globalization of travel and trade facilitates the spread of fungal pathogens across borders, resulting in a more significant global market for Terbinafine Hydrochloride products.
• Increasing number of public health awareness campaigns and educational initiatives regarding fungal infections raise awareness about the availability and efficacy of Terbinafine Hydrochloride treatments, stimulating market demand.
• Increasing disposable incomes in developing countries enable individuals to afford healthcare expenditures, including medications for treating fungal infections.

Terbinafine Hydrochloride News

The report covers the latest developments, updates, and trends impacting the global terbinafine hydrochloride industry, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in terbinafine hydrochloride production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the terbinafine hydrochloride price trend. 

Latest developments in the terbinafine hydrochloride industry:

• In 2024, Novartis revealed ALITHIOS study data demonstrating Kesimpta's sustained efficacy over six years for treatment-naïve individuals with relapsing multiple sclerosis: 44% fewer relapses, 96.4% and 82.7% MRI lesion reductions, and 24.5% and 21.6% fewer 3- and 6-month disability worsening events compared to teriflunomide switchers. Similar efficacy and safety were observed across the ALITHIOS population.
• In 2023, Taro Pharmaceutical Industries Ltd. (PINK SHEETS: (TAROF) Celebrates FDA's Final Approval of Its Abbreviated New Drug Application (ANDA) Submission for Terbinafine Hydrochloride Cream, 1%. This implies conditional approval, which is a step towards the drug pipeline expansion of Taro Biopharm.
• In 2021, Breckenridge Pharmaceutical, Inc. announced a multi-product agreement with Aggrega Pharma, LLC., covering eight products in various dosage forms. The agreement includes one approved ANDA, four submitted to the FDA, and three in advanced development stages.

Product Description

Terbinafine Hydrochloride is an active pharmaceutical ingredient that is majorly employed for the treatment of superficial fungal infections of the skin and nails such as athlete's foot, jock itch, and ringworm. It is a representative of the class of antifungal drugs known as allylamines, which work on ergosterol synthesis inhibition reducing the membrane function, andergogenicity, and growth and reproduction of fungi. The compound is commonly prepared in the laboratory by the multi-step oxidation of the starting compounds to produce the active ingredient. 

Terbinafine hydrochloride occupies an important position in dermatology and podiatry being a very effective drug for the cure of skin and nail fungal infections and, therefore, a pain relief as well as a relief from itching, redness, scaling, and discomfort. The advantages, such as high therapeutic efficacy, easy application, and fewer potential adverse reactions than others are the main features. Terbinafine hydrochloride is present widely in both over-the-counter and prescription formulations, which makes it available to patients with curative effects and simple treatment modalities for fungal infections targeting the skin and nails.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of terbinafine hydrochloride pricing, covering global and regional trends, spot prices at key ports, and a breakdown of FOB and CIF prices. 
• The study examines factors affecting terbinafine hydrochloride price trend, including input costs, supply-demand shifts, and geopolitical impacts, offering insights for informed decision-making. 
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning. 
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The terbinafine hydrochloride price charts ensure our clients remain at the forefront of the industry.